Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Apoptosis of polymorphonuclear leukocytes (PMNs) is a critical step in the resolution of tissue inflammation. PMN apoptosis has been studied extensively in vitro, and diverse inflammatory mediators have been shown to modulate the process. The reported effects of interleukin-6 (IL-6) on PMN apoptosis are inconsistent; however, analysis of published studies reveals at least one discriminating factor–the use of varied concentrations of PMNs in the experimental design. Consequently, we hypothesized that the in vitro effects of IL-6 on PMN apoptosis varied with the concentration of PMNs in culture. PMNs isolated from healthy human donors were cultured at concentrations from 1 to 20 × 106/mL, and incubated with IL-6 doses from 1 to 100 ng/mL. PMNs cultured at 1–5 × 106/mL were unaffected by IL-6; in contrast, IL-6 inhibited apoptosis in PMNs cultured at 10–20 × 106/mL, compared with untreated similarly concentrated PMNs. These data suggest caution in interpreting in vitro studies of apoptosis; on the other hand, appropriately designed experiments may help elucidate the regulation of apoptosis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Lee, A., Whyte, M. K. B., & Haslett, C. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.4.283 · Cited by 714 · cited 1×
“Inhibition of PMN apoptosis by these mediators can prolong PMN functional integrity in vitro [4]; this effect could potentiate PMN-mediated cytotoxicity and organ dysfunction in vivo.”
Background
Cited by
Raffaghello, L., Bianchi, G., Bertolotto, M., Montecucco, F., Busca, A., Dallegri, F., Ottonello, L., & Pistoia, V. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0416 · Cited by 517
The bovine neutrophil: Structure and function in blood and milk
(2003) · Veterinary Research · doi:10.1051/vetres:2003024 · Cited by 492
Molecular control of neutrophil apoptosis
Akgul, C., Moulding, D. A., & Edwards, S. W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02324-3 · Cited by 488
Neutrophil Apoptosis in the Acute Respiratory Distress Syndrome
MATUTE-BELLO, G., LILES, W. C., RADELLA, F., STEINBERG, K. P., RUZINSKI, J. T., JONAS, M., CHI, E. Y., HUDSON, L. D., & MARTIN, T. R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.96-12081 · Cited by 394
Mcl-1 Expression in Human Neutrophils: Regulation by Cytokines and Correlation With Cell Survival
Moulding, D. A., Quayle, J. A., Hart, C. A., & Edwards, S. W. (1998) · Blood · doi:10.1182/blood.v92.7.2495 · Cited by 355
Neutrophil apoptosis pathways and their modifications in inflammation
Simon, H. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00038.x · Cited by 347
IL-6 signalling pathways and the development of type 2 diabetes
Akbari, M., & Hassan-Zadeh, V. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0458-0 · Cited by 302
Murray, J., Barbara, J. A. J., Dunkley, S. A., Lopez, A. F., Van Ostade, X., Condliffe, A. M., Dransfield, I., Haslett, C., & Chilvers, E. R. (1997) · Blood · doi:10.1182/blood.v90.7.2772 · Cited by 294
Role of neutrophils in innate immunity: A systems biology-level approach
Kobayashi, S. D., & DeLeo, F. R. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.32 · Cited by 259
Environmental immune disruptors, inflammation and cancer risk
Thompson, P. A., Khatami, M., Baglole, C. J., Sun, J., Harris, S. A., Moon, E.-Y., Al-Mulla, F., Al-Temaimi, R., Brown, D. G., Colacci, A. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv038 · Cited by 227
Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection
Dalrymple, S. A., Slattery, R., Aud, D. M., Krishna, M., Lucian, L. A., & Murray, R. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3231-3235.1996 · Cited by 197
“It has also recently been reported that certain concentrations of rIL-6 can suppress apoptosis of neutrophils in vitro (3).”
BackgroundMacrophage-Induced Neutrophil Apoptosis
Meszaros, A. J., Reichner, J. S., & Albina, J. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.435 · Cited by 161
Macrophage phagocytosis of wound neutrophils
Meszaros, A. J., Reichner, J. S., & Albina, J. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.1.35 · Cited by 103
In Vivo Interleukin-6 Protects Neutrophils from Apoptosis in Osteomyelitis
Asensi, V., Valle, E., Meana, A., Fierer, J., Celada, A., Alvarez, V., Paz, J., Coto, E., Carton, J. A., Maradona, J. A., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.3823-3828.2004 · Cited by 93
“However, it has been shown that IL-6 inhibits constitutive Bax expression (6, 33), which may play a major role in neutrophil survival.”
BackgroundResultInfluentialNeutrophils in innate immunity and systems biology‐level approaches
Rungelrath, V., Kobayashi, S. D., & DeLeo, F. R. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1458 · Cited by 72
Metadata
- Authors
- Biffl, W. L., Moore, E. E., Moore, F. A., & Barnett, C. C.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-11-01
- Volume
- 58
- Issue
- 5
- Pages
- 582-584
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2113700852
- Cited by
- 109
- References
- 2
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.